SCHEMBL6908555

SCHEMBL6908555

CCCCc1sccc1S(=O)(=O)N(C(N)=O)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.36
ESR1 P03372 1/20 0.36
LMNA P02545 3/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNA2 P20248 1/20 0.36
CCND1 P24385 1/20 0.36
CDK2 P24941 1/20 0.36
CDK7 P50613 1/20 0.36
CCNH P51946 1/20 0.36
CCNA1 P78396 1/20 0.36
CDK6 Q00534 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
ALOX5 P09917 1/20 0.35
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
LTB4R Q15722 1/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6913312 0.89 LMNA (0.40) POLBESR1LMNATP53THRB
SCHEMBL7646542 0.79 NPSR1 (0.40) POLBLMNATP53THRBCDK1
SCHEMBL7640477 0.78 NPSR1 (0.41) POLBESR1LMNATP53THRB
SCHEMBL7643240 0.78 NPSR1 (0.55) POLBLMNATP53THRBCDK1
SCHEMBL7647135 0.76 ALDH1A1 (0.41) POLBLMNATP53THRBCDK1
SCHEMBL7641009 0.76 ALOX5 (0.39) POLBESR1LMNATP53CDK1
SCHEMBL27341802 0.72 CA2 (0.46) LMNA
SCHEMBL20981709 0.70 HCRTR2 (0.43) POLBESR1CDK1CCNB1CCNA2
SCHEMBL6157351 0.68 CA2 (0.47)
SCHEMBL875443 0.68 CA12 (0.49) TP53KMT2ATDP1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6683103-B2 SULFONAMIDES CONTAINING OXAZOLE AND SUBSTITUTED THIOPHENE RINGS, USEFUL FOR TREATING HYPERTENSION, CARDIOVASCULAR DISEASE, ASTHMA, PULMONARY HYPERTENSION, INFLAMMATORY DISEASES, VISION DEFECTS, MENSTRUAL DISORDERS, RENAL FAILURE TEXAS BIOTECHNOLOGY CORPORATION 2004-01-27 US disclosed
US-6432994-B1 CARDIOVASCULAR DISORDERS, GLAUCOMA; ANTIINFLAMMATORY, WOUND HEALING, HYPOTENSIVE, ANTIASTHMATIC, AND ANTIANAPHYLACTIC AGENTS TEXAS BIOTECHNOLOGY CORPORATION 2002-08-13 US disclosed
US-6248767-B1 VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORP. 2001-06-19 US disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed